Actions of an IGF-I-enhancing antibody on IGF-I pharmacokinetics and tissue distribution: Increased IGF-I bioavailability

Journal of Endocrinology

Volumn 152, Issue 1, 1997, Pages 123-130

  Hill, R A ^b   Flick Smith, H C ^a   Dye, S ^a   Pell, J M ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b Tropical Beef Centre   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN; SOMATOMEDIN;

ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; DRUG TISSUE LEVEL; HORMONE BLOOD LEVEL; HORMONE RELEASE; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

EID: 0031030020     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1520123     Document Type: Article

References (28)

1. Aston R, Cowden WB & Ada GL 1989 Antibody mediated enhancement phenomena. Molecular Immunology 25 271-275
2. Ballard FJ, Knowles SE, Walton PE, Owens PC, Mohler MA & Ferraiolo BL 1991 Plasma clearence and tissue distribution of labelled insulin-like groth factor-I (IGF-I), IGF-II and des(1-3)IGF-I in rats. Journal of Endocrinology 128 197-204.
3. 3IGF-I in pregnant rats. Journal of Endocrinology 138 327-336.
4. Baxter RC & Martin JL 1989 Structure of the Mr 140 000 growth hormone-dependent insulin-like growth factor-binding protein complex: determination by reconstitution and affinity labeling. Proceedings of the National Academy of Sciences of the USA 86 6878-6902.
5. Blat C, Villaudy J & Binoux M 1994 In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. Journal of Clinical Investigation 93 2286-2290.
6. Bradford MM 1976 A rapid and sensitive method for the quantkation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistr 72 248-254.
7. Charlton HM, Clark RG, Robinson ICAF, Goff AEP, Cox BS, Bugnon C & Bloch BA 1988 Growth hormone-deficient dwarfism in the rat: a new mutation. Journal of Endocrinology 119 51-58.
8. Cwyfan-Hughes SC, Wass JAH & Holly JMP 1993 Two site-specific radioimmunoassays which demonstrate the presence of proteolytically modified insulin-like growth factor binding protein-3 in the circulation. Journal of Endocrinology 137 321-328.
9. Gray RS, Cowan P, di Mario J, Elson RA, Clarke BF & Duncan LJP 1985 Influence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabetics. British Medical Journal 290 1687-1692.
10. Holder AT 1992 GH antibodies and somatic growth. In Regulation of Growth Hormone and Somatic Growth, pp 363-398. Ed L S De la Cruz. Amsterdam: Elsevier Science Publishers.
11. Jones JI & Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 16 3-34.
12. Kerr DE, Laarveld B & Manns JG 1990 Effects of passive immunization of growing guinea pigs with an insulin-like growth factor-I monoclonal antibody. Journal of Endocrinology 124 403-415.
13. Koea JB, Gallaher BW, Breier BH, Douglas RG, Hodgkinson S, Shaw JHF & Gluckman PD 1992 Passive immunization against circulating insulin-like growth factor-I (IGF-I) increases protein catabolism in lambs: evidence for a physiological role for circulating IGF-I. Journal of Endocrinology 135 279-284.
14. Lewitt MS, Saunders H & Baxter RC 1994 Bioavailability of insulin-like growth factors (IGFs) in rats determined by the molecular distribution of human IGF-binding protein-3. Endocrinology 133 1797-1802.
15. Liu J-P, Baker J. Perkins AS, Robertson EJ & Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igflr). Cell 75 59-72.
16. Massait S, Maiter D, Portetelle D, Adam E, Renaville, R & Ketelslegers J-M 1993 Monoclonal antibodies to bovine growth hormone (GH) potentiate hormonal activity in vivo by enhancing GH binding to hepatic somatogenic membranes. Journal of Endocrinology 139 383-393.
17. Mazza MM & Retegui LA 1989 Monoclonal antibodies to human growth hormone induce an allosteric confomational change in the antigen. Immunology 67 148-153.
18. Pell JM & Aston R 1995 Principles of immunomodulation. Livestock Production Science 42 123-133.
19. Pell JM & James S 1995 Immuno-enhancement and -inhibition of growth hormone-releasing factor by site-directed anti peptide antibodies in vivo and in vitro. Journal of Endocrinology 146 535-541.
20. Pell JM, Johnsson ID, Pullar RA, Morrell DJ, Hart IC, Holder AT & Aston R 1989 Potentiation of growth hormone activity in sheep using monoclonal antibodies. Journal of Endocrinology 120 R15-R18.
21. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N & Stewart TA 1993 IGF-I is required for normal embryonic growth in mice. Genes and Development 7 2609.
22. Rechler MM 1994 Insulin-like growth factor binding proteins. Vitamins and Hormones 47 1-114.
23. Salacinski PRP, McLean C, Sykes JEC, Clement-Jones V & Lowry PJ 1981 Iodination of proteins, glycoproteins and peptides using a solid-phase oxididising agent 1, 3, 4, 6,-tetrachloro-3α, 6α-diphenyl lycouril (Iodogen). Analytical Biochemistry 117 136-146.
24. Spencer GSG, Hodgkinson SC & Bass JJ 1991 Passive immunization against insulin-like growth factor-I does not inhibit growth hormone-stimulated growth in dwarf rats. Endocrinology 128 2103-2109.
25. Stewart CEH, Bates PC, Calder TA, Woodall SM & Pell JM 1993 Potentiation of insulin-like growth factor-I by an antibody: supportive evidence for enhancement of IGF-I bioavailability in vivo by IGF binding proteins. Endocrinology 133 1462-1465.
26. Wang BS, Lumanglas AL, Szewczyk E, McWilliams W, Loullis CC & Hart IC 1992 A proposed mechanism of action of a growth hormone-specific monoclonal antibody in the enhancement of hormonal activity. Molecular Immunology 29 313-317.
27. Xian CJ, Shoubridge CA & Read LC 1995 Degradation of IGF-I in the adult rat gastrointestinal tract is limited by a specific antiserum or the dietary protein casein. Journal of Endocrinology 146 215-225.
28. Zapf J, Waldvogel M & Froesch ER 1986 Acute metabolic effects and half-lives of intravenously administered insulin-like growth factor I and II in normal and hypophysectomized rats. Journal of Clinical Investigation 77 1768-1775.